Chronic respiratory diseases such as asthma and COPD are typically managed by daily
inhaled medication. However, the efficacy of an inhaled medication depends upon a …

BACKGROUND Medication non-adherence management of patients with asthma/COPD
remains challenging. Given the multitude of underlying causes, a personalized approach is …

Nonadherence to treatment, and its associated health and economic burden, is particularly
problematic in asthma and chronic obstructive pulmonary disease management because of …

Adherence to medication comprises a multiphased temporal process involving (1) initiation
of prescribed therapy,(2) implementation as prescribed, and (3) subsequent persistence …

Adequate medication adherence is key for optimal benefit of pharmacological treatments. A
wealth of research has been conducted to understand and identify opportunities to intervene …

Adherence broadly encompasses the decisions patients make as to whether health care
advice should be initiated, as well as the degree to which the recommended health …

Suboptimal adherence to pharmacological treatment of asthma and chronic obstructive
pulmonary disease (COPD) has adverse effects on disease control and treatment costs. The …

Adherence to asthma medications is generally poor and undermines clinical outcomes. Poor
adherence is characterized by underuse of inhaled corticosteroids (ICS), often accompanied …

Medication non-adherence to asthma and chronic obstructive pulmonary disease therapy
poses a significant burden for patients and societies. Non-adherence encompasses poor …

Nonadherence in asthma treatment results in increasing mortality, morbidity, and it is
associated with increasing treatment costs. In asthma, adherence rates are often below …